Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch
2019/06/22 by G. Deceuninck, Geneviève Deceuninck, B. Lefebvre +9 · 24 citations
Immunology and Microbiology · Medicine · #Bacterial Infections and Vaccines #Pneumonia and Respiratory Infections #Cystic Fibrosis Research Advances
paper · doi:10.1016/j.vaccine.2019.06.021
Cited by
- Long-Term Protection Against Invasive Meningococcal B Disease and Gonococcal Infection 5 Years After Implementation of Funded Childhood and Adolescent 4CMenB Vaccination Program in South Australia: An Observational Cohort and Case-Control Study
- Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story. [europepmc]
- Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine. [europepmc]
- TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. [europepmc]
- Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018). [europepmc]
- Vaccines against Meningococcal Diseases. [europepmc]
- Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018. [europepmc]
- Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. [europepmc]
- Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B. [europepmc]
- Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice. [europepmc]
- Meningococcal disease and vaccination in college students. [europepmc]
- Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France. [europepmc]
- Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India. [europepmc]
- Preventing invasive meningococcal disease in early infancy. [europepmc]
- [Infectious Disease Prevention Group: Update on vaccines, 2022]. [europepmc]
- Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review. [europepmc]
- Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy. [europepmc]
- 4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion. [europepmc]
- A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure. [europepmc]
- 4CMenB journey to the 10-year anniversary and beyond. [europepmc]
- 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults. [europepmc]
- Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region. [europepmc]
- Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. [europepmc]
- Need for Invasive Meningococcal Disease Prevention Through Vaccination for Young Children in the Americas. [europepmc]